Novonesis (Novozymes) A/S (NSIS-B.CO) — Quality & forensics

As of 2026-09-03 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

46 /100 composite · 7 modules · general weight set

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

24.48 Altman Z-Score

Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

6/8 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-2.65 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

FAQ · from the current data · as of 2026-09-03

Quick answers

What is Novonesis (Novozymes) A/S's Closelook quality reading?

The composite reads 46/100 across 7 modules, as of 2026-09-03: valuation 16, quality 44, growth 55, balance sheet 45, cash quality 57, capital allocation 39, momentum 78. Closelook scores are research diary readings, not ratings or investment advice.

What is Novonesis (Novozymes) A/S's Altman Z-Score?

24.48, which sits in the safe zone (above 2.99) as of 2026-09-03. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Novonesis (Novozymes) A/S's Piotroski F-Score?

6 of 8, as of 2026-09-03. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Novonesis (Novozymes) A/S's Beneish M-Score indicate?

-2.65 — below the −1.78 manipulation-risk threshold, as of 2026-09-03. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.

Related in the Closelook universe